BCC Research’s latest Pulse Report examines how AI is advancing biomarker identification, drug discovery, clinical trial ...
SAN DIEGO, Feb. 25, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and ...
With more accessible AI models shifting the landscape of cancer research and treatments, scientists weigh in on whether AI ...
Researchers are rethinking how we target bowel cancer growth pathways, using patient-derived organoids to identify whether hyperactivating growth genes, rather than inhibiting them, improves outcomes.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果